Aller au contenu
Capteurs et mesuresRevue des preuves3 min read

Wearables for chronic disease monitoring: mostly wrist bands tracking movement, in 61 studies

Collectif éditorial MoveVitals · Study published · Reading updated

Original paper:Wearable Devices for Remote Monitoring of Chronic Diseases: Systematic Review. · JMIR mHealth and uHealth · 2026 · Article original ↗

À retenir

Across 61 studies of wearables for remote chronic disease monitoring, 39 (64%) used wearable bands, accelerometers were the most common sensor (n=39, 64%), and the wrist was the most common site. Most of the work targeted neurological (34%) and cardiovascular (25%) disease, and this mapping review does not test whether the devices improve health.

Study design

Revue des preuves

Reading basis

Published abstract

Reading focus

Design & applicability

Cette explication éditoriale existe en anglais, chinois simplifié et chinois traditionnel. Cette interface affiche la lecture en anglais.

Question de recherche

Wearables can collect health data at a distance, supporting outpatient care for chronic disease, but disease-specific studies make it hard to standardize remote monitoring systems. The authors mapped which wearables, sensors, health parameters, body locations and medical applications appear across chronic disease research.

Population et méthode

Systematic review searching PubMed, Web of Science and Scopus. After screening 1160 articles, the authors selected 61 on cardiovascular, cancer, neurological, metabolic, respiratory and other diseases, and organized them with an analysis method built around five objectives: devices, sensor types, health parameters, body locations and medical applications.

Résultats

The authors’ reported results. Read each estimate with its population and uncertainty.

  1. 1
    Device type: 39 of 61 articles (64%) used wearable bands, such as smartwatches, wristbands, armbands and straps.
  2. 2
    Sensors: accelerometers (n=39, 64%), photoplethysmographic sensors (n=18, 30%), biopotential meters (n=17, 28%), pressure meters (n=11, 18%) and thermometers (n=9, 15%).
  3. 3
    Parameters measured: acceleration (n=39, 64%), heart rate (n=24, 39%), body temperature (n=9, 15%), blood pressure (n=8, 13%) and peripheral oxygen saturation (n=7, 11%). Common body locations were the wrist, then the upper arm and the chest.
  4. 4
    Applications were neurological (n=21, 34%) and cardiovascular disease (n=15, 25%). Wellness and lifestyle monitoring appeared in 39 studies (64%), mainly activity (n=39, 100%) and sleep (n=10, 26%).

Limites et incertitude

  1. 1
    This is a descriptive map of what devices were used, not an assessment of accuracy, clinical benefit or patient outcomes.
  2. 2
    Only 61 of 1160 screened articles were selected from three databases, so the picture may not capture all device types, especially newer ones.
  3. 3
    The abstract gives no information on study quality or sample sizes, and the authors themselves call for pragmatic clinical trials with medically certified devices.

Mise en perspective

Most chronic-disease wearable research relies on wrist-worn motion sensing with heart rate, rather than on blood pressure or oxygen sensors. Consumer devices are not substitutes for medical monitoring; discuss any readings that worry you, or use of a device for a condition, with your clinician.

Vos données

This matches what many people already record: activity, heart rate and sleep from a wrist device. Use the same device and wear position, and compare trends over weeks rather than single readings; blood pressure and oxygen readings from wearables are less common and should not replace a validated cuff or medical advice.

Comprendre ce type de preuve

Check which designs were included, how searches and bias assessment were conducted, and the last search date. Publication date alone does not make the underlying evidence current.

Résumé structuré des auteurs English

Le résumé original en anglais est reproduit avec attribution sous la licence ouverte indiquée. Il s’agit d’une source, pas d’une interprétation MoveVitals. L’analyse préparée figure ci-dessus ; vérifiez les conclusions importantes dans la source.

Background

Wearable devices enable the remote collection of health parameters, supporting the outpatient care plans recommended by the World Health Organization to manage chronic diseases. While disease-specific monitoring is accurate, a comprehensive analysis of wearables across various chronic diseases helps to standardize remote patient monitoring systems.

Objective

This review aimed to identify wearables for remote monitoring of chronic diseases, focusing on (1) wearable devices, (2) sensor types, (3) health parameters, (4) body locations, and (5) medical applications.

Methods

We developed a search strategy and conducted searches across three databases: PubMed, Web of Science, and Scopus. After reviewing 1160 articles, we selected 61 that addressed cardiovascular, cancer, neurological, metabolic, respiratory, and other diseases. We created a data analysis method based on our 5 objectives to organize the articles for a comprehensive analysis.

Results

From the 61 articles, 39 (64%) used wearable bands such as smartwatches, wristbands, armbands, and straps to monitor chronic diseases. Wearable devices commonly included various sensor types, such as accelerometers (n=39, 64%), photoplethysmographic sensors (n=18, 30%), biopotential meters (n=17, 28%), pressure meters (n=11, 18%), and thermometers (n=9, 15%). These sensors collected diverse health parameters, including acceleration (n=39, 64%), heart rate (n=24, 39%), body temperature (n=9, 15%), blood pressure (n=8, 13%), and peripheral oxygen saturation (n=7, 11%). Common sensor body locations were the wrist, followed by the upper arm and the chest. The medical applications of wearable devices were neurological (n=21, 34%) and cardiovascular diseases (n=15, 25%). Additionally, researchers applied wearable devices for wellness and lifestyle monitoring (n=39, 64%), mainly for activity (n=39, 100%) and sleep (n=10, 26%).

Conclusions

This review underscores that wearable devices primarily function as bands, commonly worn on the wrist, to monitor chronic diseases. These devices collect data on acceleration, heart rate, body temperature, blood pressure, and peripheral oxygen saturation, with a focus on neurological and cardiovascular diseases. Our findings provide a foundational road map for designing generalized remote patient monitoring systems to manage multimorbidity and support standardized terminology for interoperability across digital health systems. To translate this into practice, we recommend that future research prioritize pragmatic clinical trials with medically certified devices.

Sources et attribution

Wearable Devices for Remote Monitoring of Chronic Diseases: Systematic Review.

Tegegne MD, Niakan Kalhori SR, Haas P, Sobotta VM, Warnecke J, Deserno TM.

JMIR mHealth and uHealth · 2026-02-11

DOI: 10.2196/74071 ↗PubMed · 41671558 ↗Europe PMC · Licence indiquée: cc by ↗

Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.

Interprétation éditoriale MoveVitals · contenu éducatif · aucune évaluation clinique individuelle enregistrée

Sources vérifiées 2026-11-01

Guides pratiques

À lire ensemble

·Étude de cohorte

Activity–stroke and heart attack curves differ by accelerometer processing method

Among 90,237 UK Biobank adults free of cardiovascular disease at baseline, followed until December 2022 for 1,298 strokes and 2,031 myocardial infarctions, the shape of the link between moderate-vigorous physical activity (MVPA) and each outcome depended on how the accelerometer data were processed. For stroke, hazard fell in a straight line only with the machine-learning metric; for myocardial infarction, two metrics gave a curved decline and activity counts a straight one. The abstract gives no hazard ratios, so it shows that methods disagree, not which one is right, and the findings are observational associations.

Preventive Medicine

Explications approfondiesLire l’étude →
·Validation : étude/revue

Smartwatch data as forensic evidence: heart rate is best validated, the rest uneven

A systematic review and meta-analysis of studies on smartwatches from four major brands, framed around digital forensics, found that heart rate was both the most studied and the most accurate measure. Step count, distance, energy expenditure, activity classification and sleep were less consistently validated, and results varied by brand, protocol and reporting. The abstract gives no pooled numbers, and most studies were run in healthy people in laboratories, so it cannot say how a particular watch performs for a particular person in daily life.

Forensic Science International

Explications approfondiesLire l’étude →
·Synthèse de revues

Activity trackers: about 1,800 more steps a day, but small effects on other outcomes

An umbrella review of 39 systematic reviews and meta-analyses, covering 163,992 participants, found that activity trackers were associated with more physical activity (SMD 0.3–0.6), equating to about 1,800 extra steps and 40 minutes more walking per day, and with a bodyweight reduction of about 1 kg. Effects on blood pressure, cholesterol, glycosylated haemoglobin, quality of life and pain were typically small and often non-significant. The abstract does not say what else came with the trackers in these programs or how much the reviews overlap, so the gains cannot be credited to the device alone.

The Lancet Digital Health

Explications approfondiesLire l’étude →
·Validation : étude/revue

Seven sleep trackers: good at spotting sleep, weak on wake and sleep stages

In a sleep laboratory, 34 healthy young adults wore a subset of seven consumer sleep trackers for three nights. Against polysomnography every device detected sleep very well (sensitivity 0.93 or higher) but caught wake poorly (specificity 0.18–0.54), and five of the seven matched or beat research actigraphy (specificity 0.39). Sleep-stage estimates were inconsistent, and the participants were healthy adults aged 18 to 35 in a fixed 8-hour bed window, with each device tested in only 11 to 20 of them, so the results say little about people with sleep problems.

Sleep

Explications approfondiesLire l’étude →
Capteurs et mesures →